New York State Common Retirement Fund Contrafect Corp Transaction History

New York State Common Retirement Fund

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$3.19 - $4.43 $593 - $823	-186 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$3.58 - $4.9 $46,590 - $63,768	-13,014 Reduced 98.59%	186 $1,000
Q2 2020 Aug 07, 2020	BUY	$4.69 - $7.81 $61,908 - $103,092	13,200 New	13,200 $84,000

49.2K

Ticker CFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,332,700
Market Cap $1.18M
Description
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.